Sugi Predict

Sugi Predict / Compounds / SCHEMBL7149262

SCHEMBL7149262

SCHEMBL7149262

COC(OC)(C(O)Cn1cnc2cncnc21)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 1/20 0.46
▸ LTA4H P09960 1/20 0.43
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ CYP1A2 P05177 11/20 0.33
▸ CYP2C19 P33261 9/20 0.33
▸ CYP3A4 P08684 9/20 0.33
▸ ALDH1A1 P00352 7/20 0.33
▸ CYP2C9 P11712 7/20 0.33
▸ TSHR P16473 6/20 0.33
▸ LMNA P02545 4/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ HBB P68871 1/20 0.33
▸ CYP2D6 P10635 4/20 0.33
▸ USP2 O75604 4/20 0.33
▸ CLK4 Q9HAZ1 3/20 0.33
▸ AGER Q15109 3/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7140650 0.76 LTA4H (0.35) FDPSLTA4HHDAC1HDAC6
SCHEMBL10602614 0.72 FDPS (0.56) FDPSLTA4HHDAC1HDAC6CYP1A2
SCHEMBL28153339 0.71 FDPS (0.62) FDPSLTA4HHDAC1HDAC6ALDH1A1
SCHEMBL28586359 0.71 FDPS (0.52) FDPSLTA4HHDAC1HDAC6CYP1A2
SCHEMBL7144701 0.71 DUT (0.52) —
Hydrochloric Acid SCHEMBL28485022 0.70 FDPS (0.61) FDPSLTA4HHDAC1HDAC6ALDH1A1
SCHEMBL7149601 0.69 KDM4E (0.34) ALDH1A1HSD17B10
SCHEMBL7620791 0.69 HTT (0.33) ALDH1A1KMT2A
SCHEMBL7163450 0.69 FDPS (0.56) FDPSLTA4HHDAC1HDAC6CYP1A2
SCHEMBL13044680 0.68 FDPS (0.61) FDPSLTA4HHDAC1HDAC6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065146-A1 Monomeric diols, phosphate linked oligomers formed therefrom and processes for preparing COOK PHILLIP D (US) 2003-04-03 — — US disclosed
US-6448373-B1 INHIBITORS OF ENZYMES SUCH AS PHOSPHOLIPASE A2; TREATMENT OF INFLAMMATORY DISEASES INCLUDING ATOPIC DERMATITIS AND INFLAMMATORY BOWEL DISEASE ISIS PHARMACEUTICALS, INC. 2002-09-10 — — US disclosed
EP-0739351-B1 MONOMERIC DIOLS AND PHOSPHATE LINKED OLIGOMERS FORMED THEREFROM ISIS PHARMACEUTICALS INC (US) 2002-04-10 — — EP disclosed
US-5886177-A ETHYLENE GLYCOL MONOMERS JOINED VIA STANDARD PHOSPHATE LINKAGES INCLUDING PHOSPHOROTHIOATE, PHOSPHODIESTER, AND PHOSPHORAMIDATE LINKAGES; USEFUL FUNCTIONAL GROUPS INCLUDE NUCLEOBASES AS WELL AS POLAR GROUPS, HYDROPHOBIC GROUPS ISIS PHARMACEUTICALS, INC. (US) 1999-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065146-A1 Monomeric diols, phosphate linked oligomers formed therefrom and processes for preparing BPGM, PPIP5K2, PGM2 FDPS 72/4885LTA4H 1929/4885HDAC1 4393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.